Enter the MedStartr Launchathon — Aug 1–Oct 6 in NYC
< Back to companies
Ensocell Therapeutics

Ensocell Therapeutics

Hinxton, UK

Ensocell Therapeutics, founded in 2023, specializes in precision biologics for autoimmune and fibrotic diseases. The company is headquartered in Hinxton, UK, and is in the drug discovery and target identification phase with approximately 21 employees.

Get Involved in Ensocell Therapeutics
Claim This Profile →

Problem Statement

Treatment of rare monogenic diseases

Core Technology

Precision Biologics

Key Differentiators

Precision biologics

Clinical Focus

Immunology; Fibrosis

Company Info

Business Model
Platform
Founded
2023
Total Funding
16,300,000
Website
ensocell.com

Categories

Drug Discovery/Development

Disease Areas

Technologies

Precision BiologicsDrug DiscoveryTarget Identification

MedStartr Index Score

?
24

What do you think of Ensocell Therapeutics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in Ensocell Therapeutics